FDA Inspection 1079813 — OneSource Specialty Pharma Limited

OneSource Specialty Pharma Limited — FEI 3005652193

The FDA completed an inspection of OneSource Specialty Pharma Limited on February 14, 2019 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 14, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location